Systemic lupus erythematosus--disease activity, severity, treatment and costs

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

The Journal of rheumatology·2026

Phoenixin-14 May Be a Potential Limiting Neuropeptide for Exaggerated Inflammation in Familial Mediterranean Fever and Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome: A Comparative Study.

The Journal of rheumatology·2026

Multi-target Therapy with Rituximab plus Mycophenolate Mofetil versus Rituximab Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease.

The Journal of rheumatology·2026

Early life exposures association with later diagnosis of spondyloarthritis: A population-based case-control study.

The Journal of rheumatology·2026

Long-Term Safety and Efficacy of Dazukibart in Dermatomyositis: Combined Phase II Results From Double-Blind and Open-Label Extension Studies.

The Journal of rheumatology·2026

Bioelectric phase angle and appendicular skeletal muscle mass in Rheumatoid Arthritis: association with disease activity, the impact of disease and functional disability.

The Journal of rheumatology·2026

Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.

Journal of health services research & policy·2026

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Health economics review·2026

Fever of unknown origin: cost of illness study.

Open medicine (Warsaw, Poland)·2026

The potential usefulness of health asset valuation to promote health among Korean employees.

Scientific reports·2026

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Journal of clinical medicine·2026

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

BMC health services research·2026

Related Experiment Videos

Systemic lupus erythematosus--disease activity, severity, treatment and costs

Related Concept Videos

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Rheumatological manifestations occurring in patients with diabetes mellitus.

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras.

Phoenixin-14 May Be a Potential Limiting Neuropeptide for Exaggerated Inflammation in Familial Mediterranean Fever and Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome: A Comparative Study.

Multi-target Therapy with Rituximab plus Mycophenolate Mofetil versus Rituximab Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease.

Early life exposures association with later diagnosis of spondyloarthritis: A population-based case-control study.

Long-Term Safety and Efficacy of Dazukibart in Dermatomyositis: Combined Phase II Results From Double-Blind and Open-Label Extension Studies.

Bioelectric phase angle and appendicular skeletal muscle mass in Rheumatoid Arthritis: association with disease activity, the impact of disease and functional disability.

Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Fever of unknown origin: cost of illness study.

The potential usefulness of health asset valuation to promote health among Korean employees.

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

Related Experiment Videos

Systemic lupus erythematosus--disease activity, severity, treatment and costs

Related Concept Videos

Related Articles